You Position: Home > Paper
诺舒阻抗控制系统治疗月经过多的临床分析
( views:388, downloads:184 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Obstetrics and Gynecology
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.0529-567x.2013.05.013
- Key Word:
- No keyword available
Abstract： 女性正常月经周期21 ～ 35 d,经期2～7d,经量为30～50 ml.通常将经量超过80 ml或经期超过7d称为月经过多[1].功能失调性子宫出血(功血)、慢性肾功能不全、血小板减少、凝血功能障碍等均可导致月经过多,严重影响患者的生命质量.应用诺舒(NovaSure)阻抗控制系统(诺舒)行子宫内膜切除术是治疗月经过多的有效手术方式.诺舒自2001年上市至今,全球约有100万女性接受了该术式[2],且取得了满意的疗效.诺舒在国内开展较晚,中南大学湘雅三医院自2011年开始引进诺舒(美国Hologic公司生产)治疗月经过多,取得了满意的效果,现将结果报道如下.
- [1]李屹,贾杰,李荔,等.阻抗控制子宫内膜去除术（NovaSure）与微波子宫内膜去除术（MEA）治疗月经过多的临床观察[J].2012,(19).
- [2]宋菁华,李斌,刘桂芝.诺舒（NovaSure）阻抗控制子宫内膜切除系统治疗异常子宫出血的临床研究[J].2011,(12).
- [3]Samiee H,Sabet S,Moini A,etc.Endometrial ablation with the NovaSure system in Iran.[J].2011,114(1).
- [4]Kleijn JH,Engels R,Bourdrez P,etc.Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.[J].2008,115(2).
- [5]Bongers MY.Second-generation endometrial ablation treatment: Novasure.[J].2007,21(6).
- [6]Fakih M,Cherfan V,Abdallah E.Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population.[J].2011,113(2).
- [7]Davidson,B.R.,Littleton,S.S.,Dipiero,C.M.,etc.Abnormal Uterine Bleeding During the Reproductive Years[J].2012,57(3).
- [8]Whitney, Pollock,William, Jamieson.Next-generation NovaSure device for endometrial ablation: assessing ease-of-use among physicians.[J].2012,4.